As Nigeria grapples with biting economic hardship, a quieter crisis is unfolding- the pressure to provide for family has ...
EMA committee recommends approval of Eisai & Biogen’s lecanemab to treat early Alzheimer’s disease: Tokyo Saturday, November 16, 2024, 13:00 Hrs [IST] Eisai Co., Ltd. and Biog ...